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Effects of a dominant interfering mutant of FADD on signal
transduction in activated T cells
Kim Newton, Christian Kurts*, Alan W. Harris and Andreas Strasser
The cytoplasmic adaptor protein FADD is an MHC class I molecule H-2Kb [10]. The proliferation of
FADD-DN OT-I T cells was assessed after their adoptiveessential component of the death-inducing
signaling complexes (DISCs) that assemble when transfer into RIP-mOVA transgenic mice. Antigen derived
from membrane-bound OVA expressed in the pancreaticTNF receptor family members, such as Fas, are
ligated. FADD inititates the proteolytic cascade that islets and kidney proximal tubules of these mice is pre-
sented to OT-I T cells in the renal and pancreatic lymphleads to apoptosis by binding to and promoting
the autocatalytic activation of caspase-8 [1–4]. nodes, and this presentation causes the activation of the
OT-I T cells [11]. Thus, OT-I and FADD-DN OT-I TSurprisingly, FADD (but not caspase-8) is also
required for T cells to proliferate upon their cells were labeled with 5,6-carboxy-succinimidyl-fluores-
cein ester (CFSE), were injected into RIP-mOVA mice,stimulation with mitogens [5–9]. Using transgenic
mice expressing a dominant-negative mutant of and were harvested from the lymph nodes 48 hr later for
flow-cytometric analysis. The number of cell divisionsFADD (FADD-DN), we show that functional FADD
is required for T cells to proliferate in response to was determined by the fluorescent-label intensity, which
is halved with each cell division. Proliferation of OT-I Tantigens in vivo as well as to mitogens in culture.
The costimulation of wild-type and FADD-DN T cells cells was observed in the renal and pancreatic lymph
nodes but not in the inguinal lymph nodes (See Figurewith mitogens revealed that FADD-DN T cells have
a cell-autonomous defect in intracellular signaling. S1 in the Supplementary material available with this arti-
cle on the internet), and this finding indicates that prolif-In contrast to another study [6], p53 deficiency did
not rescue mitogen-induced proliferation of FADD- eration is dependent on exposure to OVA. Proliferation
of FADD-DN OT-I T cells in the renal and pancreaticDN T cells, and neither did enforced expression of
the apoptosis inhibitor Bcl-2. Like wild-type T cells, lymph nodes was impaired, as only 15%–37% of the cells
had a reduced CFSE fluorescence intensity compared toFADD-DN T cells stimulated with mitogens
mobilized intracellular calcium and activated 66%–67% of OT-I T cells. In FADD-DN T cell cultures
stimulated with mitogens, those few T cells expressingmembers of the NF-kB transcription factor family
as well as p38 mitogen-activated protein kinase low or undetectable levels of FADD-DN protein will
proliferate normally [5]. Therefore, the FADD-DN OT-I(MAPK) and p44/42 MAPK. Therefore, FADD must
act downstream of or in parallel to these signaling T cells that underwent cell division in RIP-mOVA mice
probably maintained normal FADD function. Regardless,pathways.
these results clearly demonstrate that FADD-DN expres-
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cells from FADD-DN mice in the presence of T cells
from control mice (Figure 1a). Congenic mice expressing
different isoforms of the Ly5 antigen were used to distin-
guish between FADD-DN (Ly5.2) and control (Ly5.1)Results and discussion
The effect of FADD-DN expression on T cell prolifera- T cells. When equal numbers of Ly5.11 control T cells
and Ly5.21 FADD-DN T cells were costimulated withtion in the mouse was tested with OT-I T cell receptor
(TCR)-transgenic mice. The OT-I TCR recognizes an phorbolmyristyl acetate (PMA) plus ionomycin or with
crosslinking antibodies to CD3 and CD28 (not shown),ovalbumin (OVA)-derived peptide in association with the
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Figure 1 (p532/2 or p531/1; Figure 2). We therefore conclude that
p53 is not essential for the impaired proliferation of
FADD-DN T cells.
To determine whether an inhibitor of apoptosis might
rescue the proliferation of FADD-DN T cells, we crossed
FADD-DN mice with bcl-2 transgenic mice [12]. FADD-
DN/bcl-2 doubly transgenic T cells resembled FADD-
DN T cells in their response to mitogens. For example,
after 3 days of stimulation with PMA and ionomycin,
control and bcl-2 transgenic T cells had reached approxi-
mately 1 3 106 viable cells/mL from a starting density of
1 3 105 cells/mL. In contrast, FADD-DN and FADD-
DN/bcl-2 T cells showed little sign of proliferation, and
more than 50% of the cells were apoptotic (Figure S2 in the
Supplementary material). Functional Bcl-2 was expressed
in the FADD-DN/bcl-2 T cells because, like bcl-2 T cells,
their spontaneous death in culture was delayed signifi-
cantly (Figure S2). Enforced Bcl-2 expression is therefore
unable to rescue the proliferation of FADD-DN T cells
or to prevent their death after they fail to proliferate.
Mitogen-stimulated FADD-DN T cells do not proliferate because of a T cell activation after the triggering of the TCR/CD3
cell-autonomous defect in intracellular signaling. (a) Characterization complex on the T cell surface involves mobilization ofof the proliferative defect of FADD-DN T cells by mitogenic
Ca21 from intracellular stores. To determine whethercostimulation of control and FADD-DN T cells expressing different
isoforms of the cell surface glycoprotein Ly5. (b) Either purified Ly5.21 FADD-DN T cells flux Ca21 normally in response to
control T cells (open circles) and Ly5.11 control T cells (filled circles) crosslinking antibodies to CD3, we labeled purified con-
or Ly5.21 FADD-DN T cells (strain 64, open squares; strain 60, open trol and FADD-DN T cells with the calcium-sensitivetriangles) and Ly5.11 control T cells were cocultured in 2 ng/mL
dye Indo-1 and monitored them by flow cytometry (Fig-PMA, and 0.1 mg/mL ionomycin plus 100 U/mL rmIL-2. Proliferation
was determined by cell counting. Data points represent the mean 6 ure 3). Antibodies that crosslink CD3 on the T cell surface
standard deviation (SD) for three mice of each genotype. induced a transient increase in intracellular Ca21 in control
and FADD-DN T cells. In contrast to published data
[13], we found that FADD-DN expression made no repro-
ducible difference to the proportion of responding T cells
only the control T cells proliferated. After 6 days in cul- or to the degree to which intracellular Ca21 levels were
ture, Ly5.11 T cells had increased to approximately 1 3 raised (Figure 3a). Likewise, FADD-DN T cells treated
106 viable cells/mL from a starting density of 5 3 104 with the Ca21 ionophore ionomycin showed increases in
cells/mL. In contrast, live Ly5.21 FADD-DN T cells intracellular Ca21 equivalent to those in control T cells
were fewer in number than they were at the start of (Figure 3b). These results indicate that the prolifera-
an experiment (Figure 1b). In control experiments, both tive defect of FADD-DN T cells cannot be attributed
wild-type Ly5.11 and wild-type Ly5.21 T cells prolifer- to impaired Ca21 mobilization following stimulation of
ated in response to mitogens (Figure 1b). These results the TCR.
indicate that mitogen-stimulated FADD-DN T cells do
not proliferate because of a cell-autonomous defect in Mitogenic stimuli for T cells initiate signaling pathways
intracellular signaling. that activate members of the NF-kB family of transcrip-
tion factors [14]. Given that several death receptors that
recruit FADD can signal NF-kB activation [1, 2] and thatIt has been reported that p53 deficiency rescues the prolif-
eration of FADD-DN T cells [6]. We stimulated purified T cells lacking certain NF-kB family members do not
respond to mitogens [15], we examined NF-kB DNACD41 or CD81 T cells from p53-deficient FADD-DN
mice with PMA and ionomycin or with crosslinking anti- binding activity in mitogen-stimulated FADD-DN T
cells by gel shift assays (Figure 4a). Resting T cells frombodies to CD3 and CD28, and we found that the cells
were indistinguishable from FADD-DN T cells express- FADD-DN mice or their nontransgenic littermates con-
tained two nuclear complexes that bound to the kB3 bind-ing wild-type p53. After 3–4 days of stimulation, cultures
of nontransgenic T cells incorporated three to eight times ing site from the murine rel promoter (Figure 4a, lane 4).
These complexes were upregulated in both control andmore [3H]thymidine and contained 4- to 13-fold more
viable cells than did cultures of FADD-DN T cells FADD-DN T cells after stimulation with PMA plus iono-
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Figure 2
The proliferative defect of FADD-DN T cells is
independent of p53. Purified CD41 and
CD81 T cells from FADD-DN (strain 64, open
triangles), FADD-DN p532/2 (filled circles),
p532/2 (filled stars), and control (open
squares) mice were stimulated with 2 ng/mL
PMA and 0.1 mg/mL ionomycin or with
immobilized anti-CD3 and anti-CD28
antibodies. All cultures were supplemented
with 100 U/mL rmIL-2. T cell proliferation
was measured by cell counting. Data points
represent the mean 6 SD for three to seven
mice of each genotype.
mycin (Figure 4a) or with crosslinking antibodies to CD3 of FADD-DN T cells is not a consequence of altered
NF-kB activation.and CD28 (data not shown). The slower migrating com-
plex was dominant after 4 hr of stimulation (Figure 4a,
lane 5), while the more quickly migrating complex was Primary mouse T cells activate p38 MAPK after the liga-
tion of CD3 and CD28 or after treatment with PMAmore abundant after 16 hr of stimulation (Figure 4a, lane
6). Neither complex bound to a mutated kB3 probe (Fig- and ionomycin. Consistent with this being an important
signaling event, the p38 MAPK inhibitor SB203580 wasure 4a, lanes 1–3), and these results confirm the DNA
binding specificity of the complexes. Antibodies recogniz- shown to suppress mitogen-induced T cell proliferation
[16]. To determine whether p38 MAPK activity is altereding Rel, RelA, or NF-kB1 supershifted the NF-kB com-
plexes from control and FADD-DN T cells in a similar in FADD-DN T cells, we performed Western blot analy-
sis of purified control and FADD-DN T cells by usingmanner (Figure 4a, lanes 7–15), which indicates that the
NF-kB complexes did not differ in their subunit composi- antibodies that specifically recognize the active, dually
phosphorylated form of p38 MAPK (Figure 4b). Increasedtion. These results indicate that the proliferative defect
phosphorylated p38 MAPK was detected in both control
and FADD-DN T cells after 15 min of stimulation with
Figure 3 PMA and ionomycin (Figure 4b) or with crosslinking anti-
bodies to CD3 and CD28 (data not shown). Levels of
phosphorylated p38 MAPK remained elevated after 4 hr
of stimulation but had returned to levels seen in resting
T cells after 22 hr. We also examined whether FADD-
DN T cells activate p44 and p42 MAPKs like control T
cells do. Active, phosphorylated p44 and p42 MAPK were
detected in control and FADD-DN T cells after 30 min
of stimulation with PMA and ionomycin (Figure 4b). Lev-
els of phosphorylated p44 and p42 MAPK peaked after
1–2 hr of stimulation and then gradually diminished. Con-
trol and FADD-DN T cells also showed equivalent p44
and p42 MAPK activation after CD3 and CD28 ligation
(data not shown). Therefore, the failure of FADD-DN T
cells to proliferate in response to mitogens is not because
FADD is essential for p44 and p42 MAPK activation.
In conclusion, we have established that FADD-DN T
cells cannot proliferate after stimulation with mitogens or
antigen because of a cell-autonomous defect in intracellu-Ca21 flux in FADD-DN T cells. Purified T cells from FADD-DN (strains
64 and 60) and control mice were loaded with the Ca21-sensitive lar signaling. p38, p42, and p44 MAPK activity as well as
dye Indo-1. Levels of intracellular Ca21 are indicated by the violet/blue NF-kB activation and Ca21 mobilization after TCR/CD3
fluorescence ratio. After a 1 min baseline reading, the cells were engagement seem unaltered by FADD-DN expression,stimulated with (a) 50 mg/mL anti-CD3e antibody or (b) 0.1 mg/mL
and this finding indicates that FADD must act down-ionomycin. Results are representative of three independent
experiments. stream of or in parallel to these signaling events. Further
characterization of the proteins associated with FADD in
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